Profiling beneficial and potential adverse effects of MeCP2 overexpression in a hypomorphic Rett syndrome mouse model

Corresponding Author

Department of Pharmacology and Warren Center for Neuroscience Drug Discovery, Vanderbilt University, Nashville, Tennessee, USA

Vanderbilt Kennedy Center, Vanderbilt University, Nashville, Tennessee, USA

Vanderbilt Institute of Chemical Biology, Vanderbilt University, Nashville, Tennessee, USA

Correspondence

Colleen M. Niswender, Department of Pharmacology and Warren Center for Neuroscience Drug Discovery, 12478C MRB IV, Vanderbilt University, Nashville, TN 37232, USA.

Email: colleen.niswender@vanderbilt.edu

Search for more papers by this author

留言 (0)

沒有登入
gif